These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
203 related articles for article (PubMed ID: 19284073)
21. Neointimal Modification With Scoring Balloon and Efficacy of Drug-Coated Balloon Therapy in Patients With Restenosis in Drug-Eluting Coronary Stents: A Randomized Controlled Trial. Kufner S; Joner M; Schneider S; Tölg R; Zrenner B; Repp J; Starkmann A; Xhepa E; Ibrahim T; Cassese S; Fusaro M; Ott I; Hengstenberg C; Schunkert H; Abdel-Wahab M; Laugwitz KL; Kastrati A; Byrne RA; JACC Cardiovasc Interv; 2017 Jul; 10(13):1332-1340. PubMed ID: 28683939 [TBL] [Abstract][Full Text] [Related]
22. First results of the DEB-AMI (drug eluting balloon in acute ST-segment elevation myocardial infarction) trial: a multicenter randomized comparison of drug-eluting balloon plus bare-metal stent versus bare-metal stent versus drug-eluting stent in primary percutaneous coronary intervention with 6-month angiographic, intravascular, functional, and clinical outcomes. Belkacemi A; Agostoni P; Nathoe HM; Voskuil M; Shao C; Van Belle E; Wildbergh T; Politi L; Doevendans PA; Sangiorgi GM; Stella PR J Am Coll Cardiol; 2012 Jun; 59(25):2327-37. PubMed ID: 22503057 [TBL] [Abstract][Full Text] [Related]
23. Treatment of bifurcation lesions with a drug-eluting balloon: the PEPCAD V (Paclitaxel Eluting PTCA Balloon in Coronary Artery Disease) trial. Mathey DG; Wendig I; Boxberger M; Bonaventura K; Kleber FX EuroIntervention; 2011 May; 7 Suppl K():K61-5. PubMed ID: 22027730 [TBL] [Abstract][Full Text] [Related]
24. Influence of a paclitaxel coated balloon in combination with a bare metal stent on restenosis and endothelial function: comparison with a drug eluting stent and a bare metal stent. Clever YP; Cremers B; Speck U; Dietz U; Böhm M; Scheller B Catheter Cardiovasc Interv; 2014 Aug; 84(2):323-31. PubMed ID: 23996969 [TBL] [Abstract][Full Text] [Related]
25. Two-year results and subgroup analyses of the PEPCAD China in-stent restenosis trial: A prospective, multicenter, randomized trial for the treatment of drug-eluting stent in-stent restenosis. Xu B; Qian J; Ge J; Wang J; Chen F; Chen J; Wei M; Chen Y; Yang Y; Gao R; Catheter Cardiovasc Interv; 2016 Mar; 87 Suppl 1():624-9. PubMed ID: 26775079 [TBL] [Abstract][Full Text] [Related]
26. Thin strut chrome-cobalt stent implantation for treatment of de-novo lesions in small coronary vessels: results of the RISICO Italian Registry (Registro Italiano Mini VISION nei piccolo Vasi) utilizing the Mini VISION coronary stent platform. Brambilla N; Morici N; Bedogni F; De Benedictis M; Scrocca I; Naldi M; Fiscella A; Prosperi F; Dominici M; Rebuzzi A; Colombo A; Sangiorgi GM; J Cardiovasc Med (Hagerstown); 2009 Nov; 10(11):852-8. PubMed ID: 19550353 [TBL] [Abstract][Full Text] [Related]
27. Rotational Atherectomy Combined with Drug Coated-Balloons for in-Stent Restenosis. Allan M; Vickers D; Pitney M; Jepson N Cardiovasc Revasc Med; 2019 Jul; 20(7):559-562. PubMed ID: 30217627 [TBL] [Abstract][Full Text] [Related]
28. A novel drug-coated scoring balloon for the treatment of coronary in-stent restenosis: Results from the multi-center randomized controlled PATENT-C first in human trial. Scheller B; Fontaine T; Mangner N; Hoffmann S; Bonaventura K; Clever YP; Chamie D; Costa R; Gershony G; Kelsch B; Kutschera M; Généreux P; Cremers B; Böhm M; Speck U; Abizaid A Catheter Cardiovasc Interv; 2016 Jul; 88(1):51-9. PubMed ID: 26331782 [TBL] [Abstract][Full Text] [Related]
29. The efficacy and safety of drug-eluting balloons for the treatment of in-stent restenosis as compared with drug-eluting stents and with conventional balloon angioplasty. Oh PC; Suh SY; Kang WC; Lee K; Han SH; Ahn T; Shin EK Korean J Intern Med; 2016 May; 31(3):501-6. PubMed ID: 26951915 [TBL] [Abstract][Full Text] [Related]
30. MAPT (Mono Antiplatelet Therapy) as Regular Regimen After COBRA PzF™ NanoCoated Coronary Stent (NCS) Implantation. Maillard L; Vochelet F; Peycher P; Ayari A; Barra N; Billé J; Joly P; Silvestri M; Sévilla J; Tavildari A Cardiovasc Revasc Med; 2020 Jun; 21(6):785-789. PubMed ID: 31780418 [TBL] [Abstract][Full Text] [Related]
31. Difference in clinical target lesion revascularization between a silicon carbide-coated and an uncoated thin strut bare-metal stent: the PRO-Vision study. Haine SE; Cornez BM; Jacobs JM; Miljoen HP; Vandendriessche TR; Claeys MJ; Bosmans JM; Vrints CJ Can J Cardiol; 2013 Sep; 29(9):1090-6. PubMed ID: 23422360 [TBL] [Abstract][Full Text] [Related]
32. Second-generation drug-eluting stents versus drug-coated balloons for the treatment of coronary in-stent restenosis: A systematic review and meta-analysis. Kokkinidis DG; Prouse AF; Avner SJ; Lee JM; Waldo SW; Armstrong EJ Catheter Cardiovasc Interv; 2018 Aug; 92(2):285-299. PubMed ID: 29024274 [TBL] [Abstract][Full Text] [Related]
33. Sirolimus-eluting cobalt-chromium stents: two-year clinical results from first-in-man study on the Firebird 2 stent. Xu B; Zhang Q; Yang YJ; Qiao SB; Zhang RY; Zhang JS; Hu J; Qin XW; Hong T; Li JP; Chen JL; Huo Y; Gao RL; Shen WF Chin Med J (Engl); 2008 Mar; 121(6):492-7. PubMed ID: 18364131 [TBL] [Abstract][Full Text] [Related]
34. Comparison between drug-coated balloon angioplasty and second-generation drug-eluting stent placement for the treatment of in-stent restenosis after drug-eluting stent implantation. Kang IS; Shehata I; Shin DH; Kim JS; Kim BK; Ko YG; Choi D; Jang Y; Hong MK Heart Vessels; 2016 Sep; 31(9):1405-11. PubMed ID: 26337620 [TBL] [Abstract][Full Text] [Related]
35. A prospective multicentre registry, evaluating real-world usage of the Tryton side branch stent: results of the E-Tryton 150/Benelux registry. Agostoni P; Foley D; Lesiak M; Belkacemi A; Dens J; Kumsars I; Scott B; Oemrawsingh P; Dubois C; Garcia E; Lefèvre T; Stella PR EuroIntervention; 2012 Mar; 7(11):1293-300. PubMed ID: 22433192 [TBL] [Abstract][Full Text] [Related]
36. Clinical outcome of titanium-nitride-oxide-coated cobalt-chromium stents in patients with de novo coronary lesions: 12-month results of the OPTIMAX first-in-man study. Karjalainen PP; Mikkelsson J; Paana T; Nammas W Catheter Cardiovasc Interv; 2016 Mar; 87(4):E122-7. PubMed ID: 26308878 [TBL] [Abstract][Full Text] [Related]
37. Stent coverage and neointimal proliferation in bare metal stents postdilated with a Paclitaxel-eluting balloon versus everolimus-eluting stents: prospective randomized study using optical coherence tomography at 6-month follow-up. Poerner TC; Otto S; Gassdorf J; Nitsche K; Janiak F; Scheller B; Goebel B; Jung C; Figulla HR Circ Cardiovasc Interv; 2014 Dec; 7(6):760-7. PubMed ID: 25371536 [TBL] [Abstract][Full Text] [Related]
38. First-in-man study evaluating the safety and efficacy of a second generation biodegradable polymer sirolimus-eluting stent in the treatment of patients with de novo coronary lesions: clinical, Angiographic, and OCT outcomes of CREDIT-1. Wang G; Sun Z; Jin Q; Xu K; Li Y; Wang X; Ma Y; Liu H; Zhao X; Wang B; Deng J; Guan S; Ge M; Wang X; Xu B; Han Y Catheter Cardiovasc Interv; 2015 Mar; 85 Suppl 1():744-51. PubMed ID: 25630447 [TBL] [Abstract][Full Text] [Related]
39. Percutaneous coronary intervention with oral sirolimus and bare metal stents has comparable safety and efficacy to treatment with drug eluting stents, but with significant cost saving: long-term follow-up results from the randomised, controlled ORAR III (Oral Rapamycin in ARgentina) study. Rodriguez AE; Maree A; Tarragona S; Fernandez-Pereira C; Santaera O; Rodriguez Granillo AM; Rodriguez-Granillo GA; Russo-Felssen M; Kukreja N; Antoniucci D; Palacios IF; Serruys PW; EuroIntervention; 2009 Jun; 5(2):255-64. PubMed ID: 20449934 [TBL] [Abstract][Full Text] [Related]
40. Cobalt-chromium stents in long lesions of large vessels: clinical and angiographic results. Lozano I; Cuellas C; Avanzas P; de Prado AP; Suárez C; Rondan J; Lee D; de la Hera JM; Fernández F; Morís C Tex Heart Inst J; 2011; 38(1):35-41. PubMed ID: 21423466 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]